Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy

Summary: Through in vitro kinase assays and docking studies, we report the synthesis and biological evaluation of a phenothiazine analog J54 with potent TLK1 inhibitory activity for prostate cancer (PCa) therapy. Most PCa deaths result from progressive failure in standard androgen deprivation therap...

Full description

Bibliographic Details
Main Authors: Vibha Singh, Siddhant Bhoir, Rupesh V. Chikhale, Javeena Hussain, Donard Dwyer, Richard A. Bryce, Sivapriya Kirubakaran, Arrigo De Benedetti
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004220306660